MedTrace Logo

The Gulf Implantable Cardioverter-Defibrillator Registry

NCT02491853 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1545

Last updated 2016-08-12

No results posted yet for this study

Summary

This is a prospective observational multi-center multi-national study of the characteristics and outcomes of patients receiving implantable cardioverter-defibrillators (ICD) in the Arab Gulf region. A total of 1,500 patients will be enrolled. Data on baseline clinical characteristics, ICD programming parameters, inpatient outcomes, and clinical events such as mortality and ICD discharges over 1 year of follow-up will be collected.

Conditions

  • Implantable Defibrillator User

Interventions

DEVICE

Implantable Cardioverter Defibrillator

Implantable Cardioverter Defibrillator

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Boston Scientific Corporation

    collaborator INDUSTRY

  • Gulf Heart Association

    lead OTHER

Principal Investigators

  • Alawi A. Alsheikh-Ali, MD · Sheikh Khalifa Medical City, Abu Dhabi, UAE

  • Ahmad S. Hersi, MD · King Saud University, Riyadh, KSA

  • Adel Khalifa, MD · Bahrain Defence Force Hospital, Manama, Bahrain

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • United Arab Emirates

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02491853 on ClinicalTrials.gov